Virtual Journey: ATTR Amyloidosis

Written by Jameson Kowalczyk. Medically reviewed in March 2025.

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

How ATTR cardiomyopathy may affect mental health and four strategies for seeking support.

How ATTR amyloidosis affects different organs, and what people with this condition need to know about treatment.

A look at two types of disease-modifying therapies used in the treatment of ATTR cardiomyopathy.

Understanding quality of life and why it’s an important consideration when living with and treating ATTR-CM.

Questions to discuss with your healthcare provider when changing or adding therapies for ATTR-CM.

Living with and Treating ATTR Amyloidosis